QPCTL inhibitor Therapy(Blacksmith Medicines)

N/A

Report date: 2024/04/30 13:52:30
NME

Base Information

Drug NameQPCTL inhibitor Therapy(Blacksmith Medicines)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutaminyl-peptide cyclotransferase-like protein inhibitors
TargetsGlutaminyl-peptide cyclotransferase-like protein
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBlacksmith Medicines Inc
China Registration ClassN/A

Develop Information

Active CompaniesBlacksmith Medicines Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A